Several studies found, that TRAIL was effective inducing apoptotic cell death and that the combination therapy of TRAIL and doxorubicin could overcome TRAIL resistance in a variety of soft tissue sarcoma cells [22]. This evidence concerns the gene TNFSF10 and soft tissue sarcoma.